-
Motley Fool
Why DiDi Global Stock Is Plummeting Again Today
Shares of DiDi Global (NYSE: DIDI), a China-based ride-sharing company, fell again today on worries that the Chinese government could significantly penalize the company for its recent U.S. IPO. Bloomberg News reported yesterday that the Chinese government was considering “unprecedented” penalties against DiDi. The Cyberspace Administration of China pushed back on DiDi going public, but DiDi went through with it anyway, causing the Chinese government to view the IPO as a threat to its authority, according to the report.
-
Motley Fool
Why Facebook Stock Jumped on Friday
Shares of social networking company Facebook (NASDAQ: FB) popped on Friday. The growth stock’s gain was likely driven both by better-than-expected results from social media peer Snap (NYSE: SNAP) and an upgraded 12-month price target for Facebook shares. After market close on Thursday, Snapchat parent Snap provided an early indication of how digital advertising seems to have fared during the second quarter.
-
Motley Fool
Why Nio Stock Dropped Friday
What happened The Chinese government strikes the U.S. stock market again. Though today’s news of a regulatory crackdown focuses on education companies in China, many U.S.-listed Chinese stocks are being hit this morning.
-
Motley Fool
3 Things About CRISPR Therapeutics That Smart Investors Know
Many biotech companies have been formed hoping to be first to market with CRISPR gene-editing therapies. CRISPR Therapeutics (NASDAQ: CRSP) and its development partner Vertex Pharmaceuticals (NASDAQ: VRTX) are leading the way with the CTX001 therapy for treating sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). On June 11, CRISPR Therapeutics and Vertex held a joint press conference highlighting CTX001 results, which showed that patients in a 22-person phase 1/2 clinical trial are having a “consistent and sustained response to treatment.”
-
Motley Fool
3 Top Stocks to Buy in July
The S&P 500 is up roughly 15% across 2021’s trading, but concerns related to the pandemic and inflation are also creating volatility. Airbnb (NASDAQ: ABNB) has already disrupted the travel space, and its name is virtually synonymous with the short-term vacation rental category. Surging cases of the COVID-19 delta variant might be complicating the company’s near-term outlook, but the long-term opportunity here remains very promising.
-
Insider Monkey
15 Best Cybersecurity Stocks to Buy Now
In this article we will take a look at the 15 best cybersecurity stocks to buy now. You can skip our detailed analysis of these stocks, and go directly to the 5 Best Cybersecurity Stocks to Buy Now. Cybersecurity involves the protection of devices, data, and networks from external illegal access. Cybersecurity companies offer services […]
-
Insider Monkey
10 Best Dividend Aristocrats to Buy According to Hedge Funds
In this article, we will be looking at the 10 best dividend aristocrats to buy according to hedge funds. If you want to skip our detailed analysis of dividend aristocrats, and dividend investing, you can go directly to the 5 Best Dividend Aristocrats to Buy According to Hedge Funds. According to a report by Post […]
-
Motley Fool
Why Virgin Galactic Stock Just Slid 7%
The stock of space tourism pioneer Virgin Galactic Holdings (NYSE: SPCE) was rapidly falling back to Earth on Thursday, down 7.2% as of 2:30 p.m. EDT. “We weren’t quite high enough,” says one unsatisfied space tourist. In a post on LinkedIn, Stucky said he did not leave “on my own timeline” (i.e., he was fired).
-
Motley Fool
2 Monster Stocks in the Making
Many stockholders invest in the hope of finding stocks that later deliver outsized returns. Innovative Industrial is a unique take on real estate investment trusts (REITs): It acquires and leases facilities for cannabis production to marijuana companies. Additionally, it provides another essential need that smart investors know well.
-
Motley Fool
Is Inovio Pharmaceuticals Primed For a Comeback?
It seems like a long time ago that Inovio Pharmaceuticals (NASDAQ: INO) was considered a leader in the race to develop an effective coronavirus vaccine. Unsurprisingly, investors mostly gave up on Inovio, and its shares have lost more than half their value in the past 12 months. Inovio hasn’t given up on its COVID-19 vaccine program, but the biotech can’t conduct a phase 3 clinical trial for INO-4800 in the U.S. at the moment.
-
Motley Fool
Could Nokia Be a Millionaire-Maker Stock?
Amid drastic changes to its business, Nokia (NYSE: NOK) continues to attract investor attention. Once the leading maker of mobile phones, it has redefined itself as a telecom equipment stock in the 5G era. Meme stocks do carry some potential for sharp upward moves that traders can capitalize on — but can this telecom stock generate real wealth for long-term investors?
-
Motley Fool
Why Shopify Stock Was Climbing This Week
Shares of Shopify (NYSE: SHOP) were up as much as 12.5% this week along with a broad rally in tech stocks. At least three Wall Street analysts raised their price targets on Shopify stock ahead of the company’s earnings report next week. This includes RBC Capital Markets, which boosted its price target from $1,700 to $1,800; Stifel, which raised its price target from $1,400 to $1,600; and Susquehanna, which raised its price target from $1,500 to $1,800.
